The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
A Toll-like receptor recognizes bacterial DNA
Abstract
DNA from bacteria has stimulatory effects on mammalian immune cells, which depend on the presence of unmethylated CpG dinucleotides in the bacterial DNA. In contrast, mammalian DNA has a low frequency of CpG dinucleotides, and these are mostly methylated; therefore, mammalian DNA does not have immuno-stimulatory activity. CpG DNA induces a strong T-helper-1-like inflammatory response. Accumulating evidence has revealed the therapeutic potential of CpG DNA as adjuvants for vaccination strategies for cancer, allergy and infectious diseases. Despite its promising clinical use, the molecular mechanism by which CpG DNA activates immune cells remains unclear. Here we show that cellular response to CpG DNA is mediated by a Toll-like receptor, TLR9. TLR9-deficient (TLR9-/-) mice did not show any response to CpG DNA, including proliferation of splenocytes, inflammatory cytokine production from macrophages and maturation of dendritic cells. TLR9-/- mice showed resistance to the lethal effect of CpG DNA without any elevation of serum pro-inflammatory cytokine levels. The in vivo CpG-DNA-mediated T-helper type-1 response was also abolished in TLR9-/- mice. Thus, vertebrate immune systems appear to have evolved a specific Toll-like receptor that distinguishes bacterial DNA from self-DNA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“all of the AAV-induced cytokines and chemokines can be upregulated by activation of TLR9 in the periphery using synthetic CpG-rich oligonucleotides.8,9,10,11,12,52,53,54,55,56,57,58”
From An innate immune response to adeno-associated virus genomes decreases cortical dendritic complexity and disrupts synaptic transmission (2024) · cites this paper as [52]
Citations
Cites
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. J. (1997) · Nature · doi:10.1038/41131 · Cited by 6,137
Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80119-3 · Cited by 3,680
Self-citationCpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3749 · Cited by 3,374
Self-citationInnate Immunity: The Virtues of a Nonclonal System of Recognition
Medzhitov, R., & Janeway, C. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80412-2 · Cited by 2,434
Unresponsiveness of MyD88-deficient mice to endotoxin.
Kawai, T., Adachi, O., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80086-2 · Cited by 2,367
Self-citationA family of human receptors structurally related to Drosophila Toll.
Rock, F., Hardiman, G., Timans, J., Kastelein, R., & Bazan, J. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.2.588 · Cited by 2,009
Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors
Brightbill, H. D., Libraty, D. H., Krutzik, S. R., Yang, R., Belisle, J. T., Bleharski, J. R., Maitland, M. L., Norgard, M. V., Plevy, S. E., Smale, S. T., et al. (1999) · Science · doi:10.1126/science.285.5428.732 · Cited by 1,659
Cell Activation and Apoptosis by Bacterial Lipoproteins Through Toll-like Receptor-2
Aliprantis, A. O., Yang, R., Mark, M. R., Suggett, S., Devaux, B., Radolf, J. D., Klimpel, G. R., Godowski, P. J., & Zychlinsky, A. (1999) · Science · doi:10.1126/science.285.5428.736 · Cited by 1,463
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,045
Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease
Medvedev, A. E., Sabroe, I., Hasday, J. D., & Vogel, S. N. (2006) · Journal of Endotoxin Research · doi:10.1179/096805106x102255 · Cited by 203
T granules in human platelets function in TLR9 organization and signaling
Thon, J. N., Peters, C. G., Machlus, K. R., Aslam, R., Rowley, J. W., MacLeod, H. J., Devine, M. T., Fuchs, T. A., Weyrich, A. S., Semple, J. W., et al. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201111136 · Cited by 201
“TLR9 has been identified as the receptor involved in the recognition of immunostimulatory CpG motifs (Hemmi et al., 2000; Bauer et al., 2001) and is uniquely expressed in peripheral granules in resting PLTs and on the human PLT surface after activation.”
BackgroundExtracellular DNA (eDNA). A Major Ubiquitous Element of the Bacterial Biofilm Architecture
Campoccia, D., Montanaro, L., & Arciola, C. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169100 · Cited by 222
“TRL9 is a pattern recognition receptor, which is predominantly located intracellularly in immune cells and recognizes unmethylated CpG motifs characteristic of bacterial DNA [44,45].”
BackgroundSplenic Macrophage Subsets and Their Function during Blood-Borne Infections
da Silva, H. B., Fonseca, R., Pereira, R. M., Cassado, A. D. A., Álvarez, J. M., & Lima, M. R. D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00480 · Cited by 201
“This also holds true for several other interactions such as TLR2 and/or TLR4 with glycosylphosphatidylinositol (GPI) anchors from Trypanosoma and Plasmodium parasites (7, 8) and TLR9 engagement by CpG motifs found in bacterial (9) and plasmodial DNA (10).”
BackgroundToll-like receptors and their role in experimental models of microbial infection
Qureshi, S., & Medzhitov, R. (2003) · Genes and Immunity · doi:10.1038/sj.gene.6363937 · Cited by 159
Marshall, J. S., & Jawdat, D. M. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.04.045 · Cited by 206
Wei, M., Chen, N., Li, J., Yin, M., Liang, L., He, Y., Song, H., Fan, C., & Huang, Q. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201105187 · Cited by 202
The sound of silence: Transgene silencing in mammalian cell engineering
Cabrera, A., Edelstein, H. I., Glykofrydis, F., Love, K. S., Palacios, S., Tycko, J., Zhang, M., Lensch, S., Shields, C. E., Livingston, M., et al. (2022) · Cell Systems · doi:10.1016/j.cels.2022.11.005 · Cited by 217
“122,123 An shRNA screen of baculovirus-infected A549 cells identified genes of the TLR, interferon, and interleukin families that silence trans-gene expression.”
BackgroundCritical role of AIM2 in Mycobacterium tuberculosis infection
Saiga, H., Kitada, S., Shimada, Y., Kamiyama, N., Okuyama, M., Makino, M., Yamamoto, M., & Takeda, K. (2012) · International Immunology · doi:10.1093/intimm/dxs062 · Cited by 202
Self-citationExploration of the nanomedicine-design space with high-throughput screening and machine learning
Yamankurt, G., Berns, E. J., Xue, A., Lee, A., Bagheri, N., Mrksich, M., & Mirkin, C. A. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0351-1 · Cited by 203
Gut microbiota and colorectal cancer
Gao, R., Gao, Z., Huang, L., & Qin, H. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2881-8 · Cited by 205
“TLR-9 has been proved to help the cellular response to CpG DNA of infectious pathogens [51].”
BackgroundAdvances in transcutaneous vaccine delivery: Do all ways lead to Rome?
Bal, S. M., Ding, Z., van Riet, E., Jiskoot, W., & Bouwstra, J. A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.09.018 · Cited by 201
Uehara, A., Yang, S., Fujimoto, Y., Fukase, K., Kusumoto, S., Shibata, K., Sugawara, S., & Takada, H. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00433.x · Cited by 197
“Phosphorothioate-stabilized CpG DNA 1826, as a strong human cell stimulant (TCCATGACGTTCCTGATGCT) (Hemmi et al., 2000), was obtained from Proligo.”
BackgroundCutting Edge: TLR2 Directly Triggers Th1 Effector Functions
Imanishi, T., Hara, H., Suzuki, S., Suzuki, N., Akira, S., & Saito, T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6715 · Cited by 200
“The CpG oligodeoxynucleotide (TCCATGACGTTCCTGATGCT) (15), a TLR9 ligand, was purchased from Rikaken.”
BackgroundSelf-citationToll-like receptors and T-helper-1/T-helper-2 responses
Dabbagh, K., & Lewis, D. B. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200306000-00003 · Cited by 199
Scheel, B., Teufel, R., Probst, J., Carralot, J., Geginat, J., Radsak, M. P., Jarrossay, D., Wagner, H., Jung, G., Rammensee, H., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200425656 · Cited by 198
Self-citationSpies, B., Hochrein, H., Vabulas, M., Huster, K. M., Busch, D. H., Schmitz, F., Heit, A., & Wagner, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5908 · Cited by 196
“Recently, it has been demonstrated that Toll-like receptor 9 (TLR9) is essential for CpG-ODN-induced innate immune cell activation, because TLR9-deficient mice are refractory (9).”
BackgroundSelf-citationToll-Like Receptor 9 Inhibition Confers Protection From Liver Ischemia–Reperfusion Injury
Bamboat, Z. M., Balachandran, V. P., Ocuin, L. M., Obaid, H., Plitas, G., & DeMatteo, R. P. (2009) · Hepatology · doi:10.1002/hep.23365 · Cited by 199
Innate Immunity and Neuroinflammation
Shastri, A., Bonifati, D. M., & Kishore, U. (2013) · Mediators of Inflammation · doi:10.1155/2013/342931 · Cited by 207
“Unmethylated CpG DNA TLR9 Recognition of bacteria and virus [127, 128]”
BackgroundCpG Oligodeoxynucleotides as Vaccine Adjuvants in Primates
Verthelyi, D. I., Kenney, R. T., Seder, R. A., Gam, A. A., Friedag, B., & Klinman, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1659 · Cited by 199
“It was recently established that Toll-like receptor 9 plays a critical role in CpG ODN-mediated activation of human and murine immune cells (35, 36).”
BackgroundRecent advances in the understanding of egg allergens: basic, industrial, and clinical perspectives
Mine, Y., & Yang, M. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf8001153 · Cited by 196
Stockinger, S., Reutterer, B., Schaljo, B., Schellack, C., Brunner, S., Materna, T., Yamamoto, M., Akira, S., Taniguchi, T., Murray, P. J., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7416 · Cited by 198
“The general adaptor MyD88 is involved in stimulating IFN- synthesis in the context of TLR9 signaling (50–52).”
InfluentialSelf-citationHow has neutrophil research improved our understanding of periodontal pathogenesis?
Nussbaum, G., & Shapira, L. (2011) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2010.01678.x · Cited by 203
Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system
Hanagata, N. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30197 · Cited by 199
“It was then discovered that TLR9 is the receptor of DNA containing unmethylated CpG. 3 In human beings, TLR9 is mainly expressed by B cells and plasmacytoid dendritic cells (pDCs).”
BackgroundRyan, K. A., Smith, M. F., Sanders, M. K., & Ernst, P. B. (2004) · Infection and Immunity · doi:10.1128/iai.72.4.2123-2130.2004 · Cited by 198
“Currently the best understood are TLR2, which recognizes bacterial lipoteichoic acid and peptidoglycan (36); TLR4, which binds lipopolysaccharide (31); TLR5, which binds bacterial flagellin (16); and TLR9, which recognizes unmethylated bacterial CpG DNA (17).”
BackgroundInfluentialHuman Clinical Trials of Plasmid DNA Vaccines
Liu, M. A., & Ulmer, J. B. (2005) · Advances in genetics · doi:10.1016/s0065-2660(05)55002-8 · Cited by 198
Waldner, H., Collins, M. A., & Kuchroo, V. K. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19388 · Cited by 198
Feng, C. G., Scanga, C. A., Collazo, C. M., Cheever, A. W., Hieny, S. E., Caspar, P., & Sher, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4758 · Cited by 199
Strategies for nonviral nanoparticle‐based delivery of CRISPR/Cas9 therapeutics
Chen, F., Alphonse, M., & Liu, Q. (2020) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1609 · Cited by 197
Ospelt, C., & Gay, S. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.10.010 · Cited by 198
Antimicrobial peptides and self-DNA in autoimmune skin inflammation
Gilliet, M. F., & Lande, R. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.06.008 · Cited by 207
Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives
Hu, D., Prabhakaran, H. S., Zhang, Y.-Y., Luo, G., He, W., & Liou, Y. (2024) · Critical Care · doi:10.1186/s13054-024-05069-w · Cited by 215
Endotoxin can induce MyD88-deficient dendritic cells to support Th2 cell differentiation
Kaisho, T. (2002) · International Immunology · doi:10.1093/intimm/dxf039 · Cited by 197
Self-citationToll-like receptors: a family of pattern-recognition receptors in mammals.
Armant, M. A., & Fenton, M. J. (2002) · Genome biology · doi:10.1186/gb-2002-3-8-reviews3011 · Cited by 196
Trafficking of endosomal Toll-like receptors
Lee, B. L., & Barton, G. M. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.12.002 · Cited by 214
“Multiple TLRs recognize specific nucleic acid structures: TLR3 recognizes double stranded RNA (dsRNA) [18], TLR7 and TLR8 recognize single stranded RNA (ssRNA) [19–22] and TLR9 recognizes DNA [23].”
BackgroundWang, Y., Lian, Q., Yang, B., Yan, S., Zhou, H., He, L., Lin, G., Lian, Z., Jiang, Z., & Sun, B. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005012 · Cited by 197
“For example, TLR9 senses the CpG motifs-contained DNA [7].”
BackgroundYi, A., Yoon, J.-G., Yeo, S.-J., Hong, S., English, B. K., & Krieg, A. Μ. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4711 · Cited by 195
Kyburz, D., Rethage, J., Seibl, R., Lauener, R. P., Gay, R. E., Carson, D. A., & Gay, S. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10848 · Cited by 195
Marteau, P. R., & Shanahan, F. (2003) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/s1521-6918(03)00055-6 · Cited by 201
Human Keratinocytes Express Functional CD14 and Toll-Like Receptor 4
Song, P. I., Neparidze, N., Armstrong, C. A., Ansel, J. C., Park, Y.-M., Abraham, T., Harten, B., & Zivony, A. S. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01847.x · Cited by 196
Galluzzi, L., Vacchelli, E., Eggermont, A. M. M., Fridman, W. H., Galon, J., Sautès‐Fridman, C., Tartour, É., Zitvogel, L., & Kroemer, G. (2012) · OncoImmunology · doi:10.4161/onci.20696 · Cited by 205
“The main ligand of TLR9 is bacterial/viral DNA, differing from its mammalian counterpart for the elevated frequency of unmethylated CpG dinucleotides.(178) Indeed, whereas mammalian DNA has no immunostimulatory activity, the administration of bacterial/viral DNA induces a potent Th1 immune response in vivo, which is e…”
Trez, C. D., Magez, S., Akira, S., Ryffel, B., Carlier, Y., & Muraille, É. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000494 · Cited by 194
“Analysis of various genetically deficient mouse strains revealed the requirement of CCR2 expression for the recruitment of iNOS-DC in the draining lymph nodes, whereas their activation is strongly dependent on CD40, IL-12, IFN-c and MyD88 molecules with a partial contribution of TNF-a and TLR9.”
MethodInfluentialSelf-citationInnate immune signals in atherosclerosis
Lundberg, A. M., & Hansson, G. K. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.07.016 · Cited by 200
The role of Toll-like receptors in renal diseases
Gluba-Brzózka, A., Banach, M., Hannam, S., Mikhailidis, D. P., Sakowicz, A., & Rysz, J. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.16 · Cited by 197
O’Connor, W., Harton, J. A., Zhu, X., Linhoff, M. W., & Ting, J. P. ‐. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6329 · Cited by 195
Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity
ZHANG, J., LIU, F., & Huang, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.004 · Cited by 198
Antitumor Activity of IFN-λ in Murine Tumor Models
Sato, A., Ohtsuki, M., Hata, M., Kobayashi, E., & Murakami, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7686 · Cited by 195
“This liver-targeted strategy possesses the following advantages: 1) the liver is the largest organ of the reticuloendothelial system and appropriate immunological responses could be introduced; and 2) plasmid DNA can potentially activate the TLR 9 that mediates innate immune reactions (43, 44).”
BackgroundDNA Damage Response and Immune Defense: Links and Mechanisms
Nakad, R., & Schumacher, B. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00147 · Cited by 207
Respiratory microbiome and epithelial interactions shape immunity in the lungs
Invernizzi, R., Lloyd, C. M., & Molyneaux, P. L. (2020) · Immunology · doi:10.1111/imm.13195 · Cited by 204
Tamura, S., Tanimoto, T., & Kurata, T. (2005) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2005.195 · Cited by 195
“Therefore, new and effective adjuvants may arise from the screening of materials that stimulate the function of APCs, including ganglioside GM1 and ligands of several TLRs (16-19, 79-84 ).”
BackgroundBivas‐Benita, M., van Meijgaarden, K. E., Franken, K. L. M. C., Junginger, H. E., Borchard, G., Ottenhoff, T. H. M., & Geluk, A. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.09.044 · Cited by 195
Mycobacterial Infection in TLR2 and TLR6 Knockout Mice
Sugawara, I., Yamada, H., Li, C., Mizuno, S., Takeuchi, O., & Akira, S. (2003) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2003.tb03404.x · Cited by 191
Self-citationHeckelsmiller, K., Rall, K., Beck, S., Schlamp, A., Seiderer, J., Jahrsdörfer, B., Krug, A., Rothenfußer, S., Endres, S., & Hartmann, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3892 · Cited by 194
Genetic analysis of resistance to viral infection
Beutler, B., Eidenschenk, C., Crozat, K., Imler, J., Takeuchi, O., Hoffmann, J. A., & Akira, S. (2007) · Nature reviews. Immunology · doi:10.1038/nri2174 · Cited by 190
Self-citationDifferential Response of Dendritic Cells to Human Metapneumovirus and Respiratory Syncytial Virus
Guerrero-Plata, A., Casola, A., Suárez, G., Yu, X., Spetch, L., Peeples, M. E., & Garofalo, R. P. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0287oc · Cited by 193
“As far as the CpG-mediated IFN pathway in pDCs, CpG-ODN binds to the TLR9 in the endosomal compartment (46) and, similarly to the TLR7/8 (also expressed in the cell endosomes), activates IFN production via a mechanism that requires the adaptor molecules MyD88, IRAK-1, TRAF6, and TRAF3 (47).”
BackgroundToll-Like Receptor 2 Is Required for Optimal Control of Listeria monocytogenes Infection
Torres, D., Barrier, M., Bihl, F., Quesniaux, V. J. F., Maillet, I., Akira, S., Ryffel, B., & Erard, F. (2004) · Infection and Immunity · doi:10.1128/iai.72.4.2131-2139.2004 · Cited by 191
“sponses induced by bacterial, nonmethylated DNA (16), could”
BackgroundSelf-citationNeuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9)
Iliev, A. I., Stringaris, A. K., Nau, R., & Neumann, H. (2004) · The FASEB Journal · doi:10.1096/fj.03-0670fje · Cited by 192
“Recently, unmethylated bacterial DNA has been shown to possess the capacity of inducing sustained inflammation via stimulation of TLR9 (4, 5).”
BackgroundYu, P., Lübben, W., Slomka, H., Gebler, J., Konert, M., Cai, C., Neubrandt, L., Prazeres da Costa, O., Paul, S., Dehnert, S., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.07.018 · Cited by 192
Current prospects for mRNA gene delivery
Yamamoto, A., Kormann, M., Rosenecker, J., & Rudolph, C. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.016 · Cited by 200
Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury
Yasuda, H., Leelahavanichkul, A., Tsunoda, S., Dear, J. W., Takahashi, Y., Ito, S., Hu, X., Zhou, H., Doi, K., Childs, R. W., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00461.2007 · Cited by 191
“Akira (Osaka University, Osaka, Japan) (17).”
Toll-like receptor 9 mediates CpG-DNA signaling
Chuang, T., Lee, J., Kline, L., Mathison, J. C., & Ulevitch, R. J. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.3.538 · Cited by 192
“Using the gene-deletion approach, TLR9 has been shown as an essential element of responses to CpG-DNA in mouse [47].”
Silencing or Stimulation? siRNA Delivery and the Immune System
Whitehead, K. A., Dahlman, J. E., Langer, R., & Anderson, D. G. (2011) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061010-114133 · Cited by 200
Loiarro, M., Capolunghi, F., Fantò, N., Gallo, G., Campo, S., Arseni, B., Carsetti, R., Carminati, P., Santis, R. D., Ruggiero, V., et al. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1206746 · Cited by 193
“In addition to IL-1RI and IL-1RAcP, mammals express at least 11 members (TLR1–11) of this family [5, 6], which are specialized in the recognition of microbial products, such as the lipid A moiety of Gram-negative bacterial LPS, a ligand of TLR4 [7], or nonmethylated CpG oligodeoxyribonucleotides, deriving from the bac…”
BackgroundNew generation of mucosal adjuvants for the induction of protective immunity
Yuki, Y., & Kiyono, H. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.398 · Cited by 194
“Because TLR9-knockout mice are completely defective in their responses to CpG, failing to exhibit cytokine production by macrophages, B cell proliferation and the maturation of DCs, it can be surmised that TLR9 plays an essential role in immunological responses to CpG [40].”
Toll-like receptors: function and roles in lung disease
Basu, S., & Fenton, M. J. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00323.2003 · Cited by 189
“Unmethylated CpG DNA is a TLR9 agonist that seems to have therapeutic potential in modulating eosinophilia and asthma (10, 41, 66, 71).”
BackgroundInfluentialThe effect of probiotics on immune regulation, acne, and photoaging
Kober, M.-M., & Bowe, W. P. (2015) · International Journal of Women’s Dermatology · doi:10.1016/j.ijwd.2015.02.001 · Cited by 190
“The immune system recognizes both pathogenic and commensal bacteria through the family of Toll-like receptors (TLR) (Hemmi et al., 2000).”
BackgroundThe Art of War: Innate and adaptive immune responses
Dempsey, P. W., Vaidya, S. A., & Cheng, G. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3180-y · Cited by 203
Intracellular vs extracellular recognition of pathogens – common concepts in mammals and flies
Girardin, S. E., Sansonetti, P. J., & Philpott, D. J. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02334-x · Cited by 188
Maeda, S., Akanuma, M., Mitsuno, Y., Hirata, Y., Ogura, K., Yoshida, H., Shiratori, Y., & Omata, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105381200 · Cited by 190
Toll-Like Receptor Signaling and Regulation of Cytokine Gene Expression in the Immune System
Ozato, K., Tsujimura, H., & Tamura, T. (2002) · BioTechniques · doi:10.2144/oct0208 · Cited by 189
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi–Goutières syndrome
Lim, Y. W., Sanz, L. A., Xu, X., Hartono, S. R., & Chedin, F. L. (2015) · eLife · doi:10.7554/elife.08007 · Cited by 195
“, 2014) in addition to its canonical role in sensing unmethylated CpG-rich DNA (Hemmi et al., 2000).”
BackgroundMechanisms of chemotherapy-induced behavioral toxicities
Vichaya, E. G., Chiu, G. S., Krukowski, K., Lacourt, T. E., Kavelaars, A., Dantzer, R., Heijnen, C. J., & Walker, A. K. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00131 · Cited by 197
“Interestingly, mitochondrial DNA (mtDNA) and bacterial DNA are both rich in CpG motifs which is the primary ligand of TLR-9, suggesting that mitochondrial damage induced release of mtDNA can be a potent stimulator of the immune system via TLR-9 activation (Zhang et al., 2010).”
BackgroundInfluentialBrown, B. D., Sitia, G., Annoni, A., Hauben, E., Sergi, L. S., Zingale, A., Roncarolo, M. G., Guidotti, L. G., & Naldini, L. (2006) · Blood · doi:10.1182/blood-2006-10-049312 · Cited by 187
Hossain, D. M. S., Pal, S. K., Moreira, D., Duttagupta, P. A., Zhang, Q., Won, H., Jones, J. O., D’Apuzzo, M., Forman, S. J., & Kortylewski, M. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3145 · Cited by 192
“This is consistent with the common expression of TLR9 in mouse myeloid cells (36).”
Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9
Takeshita, F., Gürsel, İ., Ishii, K. J., Suzuki, K., Gürsel, M., & Klinman, D. M. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.10.009 · Cited by 189
“Northern blot analysis of various tissues including heart, brain, spleen, lung, liver, skeletal muscle, kidney, and testis indicated that murine TLR9 (mTLR9) transcripts were most abundantly expressed in spleen [11].”
BackgroundSchnurr, M. M., Toy, T., Shin, A., Hartmann, G., Rothenfußer, S., Soellner, J., Davis, I. D., Cebon, J. S., & Maraskovsky, E. (2003) · Blood · doi:10.1182/blood-2003-06-1959 · Cited by 189
Pure Hemozoin Is Inflammatory In Vivo and Activates the NALP3 Inflammasome via Release of Uric Acid
Griffith, J. W., Sun, T., McIntosh, M. T., & Bucala, R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0713552 · Cited by 187
Andreakos, E., Foxwell, B. M. J., & Feldmann, M. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00202.x · Cited by 191
“Genomic DNA released from dying cells has also been reported to activate human DCs, but whether TLR9 or another TLR is involved in that process has not yet been shown (110).”
BackgroundInfluentialCollaboration between the innate immune receptors dectin‐1, TLRs, and Nods
Underhill, D. M. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00548.x · Cited by 195
“Bauer S, et al. Human TLR9 confers respon- siveness to bacterial DNA via species-specific CpG motif recognition.”
BackgroundInfluentialKawagoe, T., Sato, S., Jung, A., Yamamoto, M., Matsui, K., Kato, H., Uematsu, S., Takeuchi, O., & Akira, S. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061523 · Cited by 187
Self-citationHackam, D. J., & Sodhi, C. P. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.04.001 · Cited by 191
Rational designs of in vivo CRISPR-Cas delivery systems
Xu, C., Chen, G., Luo, Y., Zhang, Y., Zhao, G., Lu, Z.-D., Czarna, A., Gu, Z., & Wang, J. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.11.005 · Cited by 187
CpG Still Rocks! Update on an Accidental Drug
Krieg, A. Μ. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0340 · Cited by 184
“Five years after the discovery of the CpG motif, Toll-like receptor 9 (TLR9) was identified as the mediator of the immune stimulatory effects of CpG ODN (Hemmi et al., 2000).”
Crohn’s disease is associated with a toll-like receptor-9 polymorphism
Török, H., Glas, J., Tonenchi, L., Brünnler, G., Folwaczny, M., & Folwaczny, C. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.05.051 · Cited by 187
Role of TLR4 Tyrosine Phosphorylation in Signal Transduction and Endotoxin Tolerance
Medvedev, A. E., Piao, W., Shoenfelt, J. L., Rhee, S. H., Chen, H., Basu, S., Wahl, L. M., Fenton, M. J., & Vogel, S. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606781200 · Cited by 190
Roquilly, A., McWilliam, H. E. G., Jacqueline, C., Tian, Z., Cinotti, R., Rimbert, M., Wakim, L. M., Caminschi, I., Lahoud, M. H., Belz, G. T., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.021 · Cited by 195
DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer
Paludan, S. R., Reinert, L. S., & Hornung, V. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-018-0117-0 · Cited by 187
Induction of immune responses by DNA vaccines in large animals
Babiuk, L. A. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00574-1 · Cited by 186
Zhang, Z., Ohto, U., Shibata, T., Taoka, M., Yamauchi, Y., Sato, R., Shukla, N. M., David, S. A., Isobe, T., Miyake, K., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.081 · Cited by 195
Immune Sensing Mechanisms that Discriminate Self from Altered Self and Foreign Nucleic Acids
Bartok, E., & Hartmann, G. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.014 · Cited by 190
Resistance to CpG DNA–induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling
Rui, L., Vinuesa, C. G., Blasioli, J., & Goodnow, C. C. (2003) · Nature Immunology · doi:10.1038/ni924 · Cited by 184
“The proliferative response of B cells to CpG DNA is mediated by TLR9 and enhanced by simultaneous antibody cross-linking of the BC”
BackgroundWang, X., Moser, C., Louboutin, J., Lysenko, E. S., Weiner, D. J., Weiser, J. N., & Wilson, J. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.810 · Cited by 185
“, peptidoglycans and lipoteichoic acid) (14, 15), mycobacteria (16) and fungi (17); and TLR9 recognizes nucleic acid motifs (18).”
Pharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles
Vanpouille-Box, C., Hoffmann, J. A., & Galluzzi, L. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0043-2 · Cited by 183
The Hygiene Hypothesis of Atopic Disease–An Extended Version
Rautava, S., Ruuskanen, O., Ouwehand, A. C., Salminen, S., & Isolauri, E. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200404000-00004 · Cited by 182
Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion
Bamboat, Z. M., Ocuin, L. M., Balachandran, V. P., Obaid, H., Plitas, G., & DeMatteo, R. P. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40008 · Cited by 188
Delivery of oligonucleotides with lipid nanoparticles
Wang, Y., Miao, L., Satterlee, A., & Huang, L. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.02.007 · Cited by 184
“ONs containing unmethylated CpG dinucleotide motifs are recognized by the innate immune system through the pattern recognition receptor Toll Like Receptor 9 (TLR9) located inside the endosome [103].”
BackgroundA Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells
Hou, W.-S., & Parijs, L. V. (2004) · Nature Immunology · doi:10.1038/ni1071 · Cited by 184
“; and the TLR9 ligand cytosine-phosphate-guanine (CpG) DN”
BackgroundKrieg, A. Μ., Efler, S. M., Wittpoth, M., Adhami, M. J. A., & Davis, H. L. (2004) · Journal of Immunotherapy · doi:10.1097/00002371-200411000-00006 · Cited by 183
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
Medrano, R. F. V., Hunger, A., Mendonça, S. A., Barbuto, J. A. M., & Strauss, B. E. (2017) · Oncotarget · doi:10.18632/oncotarget.19531 · Cited by 192
“In humans, TLR9 is expressed only in pDCs and B cells [258] and recognizes unmethylated CpG motifs that are found in bacterial and viral genomes [239].”
BackgroundInteraction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System
Mohsen, M. O., Gomes, A. C., Vogel, M., & Bachmann, M. F. (2018) · Vaccines · doi:10.3390/vaccines6030037 · Cited by 183
“The homologous TLR7/8 expressed within the endosomal compartments of APCs can recognize guanine nucleotide-homologues such as loxoribine, R848, imidazouinoline components, and uridine/guanosine rich ssRNA [47].”
Background
Metadata
- Authors
- Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., & Akira, S.
- Affiliations
- Research Institute for Microbial Diseases, The University of Osaka (JP)
- Japan Science and Technology Agency (JP)
- Technical University of Munich (DE)
- Corresponding author
- Akira, Shizuo
- ORCID
- Venue
- Nature
- Published
- 2000-12-07
- Volume
- 408
- Issue
- 6813
- Pages
- 740-745
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1514540900
- Cited by
- 6,491
- References
- 33
- Citations by year
- 2026: 85 · 2025: 115 · 2024: 136 · 2023: 167 · 2022: 156 · 2021: 191 · 2020: 180 · 2019: 164 · 2018: 187 · 2017: 219 · 2016: 201 · 2015: 226 · 2014: 276 · 2013: 281 · 2012: 235
- FWCI
- 102.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Japan Society for the Promotion of Science
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- TLR9, CpG, innate immunity, T helper 1 response, adjuvants, vaccination, dendritic cell maturation, macrophage cytokine production, self-DNA, TLR9-deficient mice
- MeSH terms
- Amino Acid Sequence, Animals, Antigens, Differentiation, Base Sequence, Cells, Cultured, Cloning, Molecular, Dendritic Cells, DNA-Binding Proteins, DNA, Bacterial, T-Lymphocytes, Helper-Inducer, Humans, Membrane Glycoproteins, Mice, Inbred C57BL, Molecular Sequence Data, Receptors, Cell Surface, Receptors, Immunologic, Dinucleoside Phosphates, Signal Transduction, Cytokines, Mutagenesis, Sequence Homology, Amino Acid, Drosophila Proteins, Adaptor Proteins, Signal Transducing, Toll-Like Receptors, Toll-Like Receptor 9, Mice, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review